Content Type: Research Publications

Generic but Expensive: Why Prices Can Remain High for Off-Patent Drugs

March 15, 2026

Designing Comparative Effectiveness Research on Prescription Drugs: Lessons From the Clinical Trial Literature

March 15, 2026

The Consequences of Requesting “Dispense as Written”

March 15, 2026

Preferences for and Experiences with Pill Appearance Changes: National Surveys of Patients and Pharmacists

March 15, 2026

Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes

March 15, 2026

A New Wave of Vaccines for Non-Communicable Diseases: What Are the Regulatory Challenges?

March 15, 2026

Battling Over Patents: The Impact of Oil States on the Generic Drug Industry

March 15, 2026

Prevalence of Publicly Available Expanded Access Policies

March 15, 2026

Drug Development and FDA Approval, 1938-2013

March 15, 2026

Assessment of Prices for Cardiovascular Tests and Procedures at Top-Ranked US Hospitals

March 15, 2026

The 505(B)(2) Drug Approval Pathway

March 15, 2026

Existing FDA Pathways Have Potential to Ensure Early Access To, and Appropriate Use Of, Specialty Drugs

March 15, 2026